000 01406 a2200421 4500
005 20250512043456.0
264 0 _c19881108
008 198811s 0 0 eng d
022 _a0022-202X
024 7 _a10.1111/1523-1747.ep12475650
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFukui, Y
245 0 0 _aLymphokine-activated killer (LAK) activity against autologous malignant tumors of the skin.
_h[electronic resource]
260 _bThe Journal of investigative dermatology
_cOct 1988
300 _a319-22 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCarcinoma, Basal Cell
_xgenetics
650 0 4 _aCarcinoma, Squamous Cell
_xgenetics
650 0 4 _aCell Line
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aDose-Response Relationship, Immunologic
650 0 4 _aFemale
650 0 4 _aHLA Antigens
_xgenetics
650 0 4 _aHumans
650 0 4 _aInterleukin-2
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aLymphocyte Activation
650 0 4 _aMale
650 0 4 _aMelanoma
_xgenetics
650 0 4 _aMiddle Aged
650 0 4 _aSkin Neoplasms
_xgenetics
700 1 _aIseki, R
700 1 _aOhashi, M
773 0 _tThe Journal of investigative dermatology
_gvol. 91
_gno. 4
_gp. 319-22
856 4 0 _uhttps://doi.org/10.1111/1523-1747.ep12475650
_zAvailable from publisher's website
999 _c3268459
_d3268459